Company Sequent Scientific Limited NSE India S.E.

Equities

SEQUENT

INE807F01027

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:56 28/06/2024 pm IST 5-day change 1st Jan Change
116.9 INR -0.59% Intraday chart for Sequent Scientific Limited -4.10% +2.80%

Business Summary

SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.

Number of employees: 1,301

Sales per Business

INR in Million2022Weight2023Weight Delta
Veterinary Healthcare
100.0 %
14,128 100.0 % 14,209 100.0 % +0.57%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
40.5 %
5,942 42.1 % 5,755 40.5 % -3.15%
Asia
33.5 %
3,899 27.6 % 4,764 33.5 % +22.16%
Rest of the World
26.0 %
4,286 30.3 % 3,690 26.0 % -13.90%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 11/22/11
Director of Finance/CFO - 06/11
Chief Administrative Officer - 01/14/01
Chief Tech/Sci/R&D Officer - 01/19/01
Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 55 17/20/17
Chairman 76 25/20/25
Director/Board Member 64 25/20/25
Director/Board Member 56 28/14/28
Chief Executive Officer 55 11/22/11
Director/Board Member 60 07/23/07
Director/Board Member - 06/20/06
Director/Board Member - 14/20/14
Chief Administrative Officer - 01/14/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 249,480,995 114,085,797 ( 45.73 %) 412,250 ( 0.1652 %) 45.73 %

Shareholders

NameEquities%Valuation
The Carlyle Group LP (Global Private Equity)
52.78 %
131,680,103 52.78 % 163 M ₹
quant Money Managers Ltd.
4.861 %
12,128,366 4.861 % 15 M ₹
White Oak Capital Partners Pte Ltd.
1.635 %
4,078,604 1.635 % 5 M ₹
The Public Sector Pension Investment Board
1.068 %
2,663,806 1.068 % 3 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.2486 %
620,305 0.2486 % 769 147 ₹
Motilal Oswal Asset Management Co. Ltd.
0.0818 %
204,015 0.0818 % 252 968 ₹
ITI Asset Management Ltd. (India)
0.0498 %
124,339 0.0498 % 154 174 ₹
Government of India
0.009179 %
22,900 0.009179 % 28 395 ₹
Groww Asset Management Ltd.
0.000380 %
948 0.000380 % 1 175 ₹

Company contact information

SeQuent Scientific Ltd.

301/A, Dosti Pinnacle Plot No.E7, Road No. 22, 3rd Floor

400604, Mumbai

+91 22 4111 4777

http://www.sequent.in
address Sequent Scientific Limited(SEQUENT)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
  1. Stock Market
  2. Equities
  3. SEQUENT Stock
  4. SEQUENT Stock
  5. Company Sequent Scientific Limited